Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia
Abstract
BACKGROUND: This study investigated whether small dense low-density lipoprotein cholesterol (sdLDL-C) can predict long-term coronary artery disease (CAD) events in patients with stable CAD without metabolic dyslipidemia. METHODS AND RESULTS: Directly measured sdLDL-C was evaluated in 396 male and 144 female patients with stable CAD who had high-density lipoprotein cholesterol (HDL-C) ≥40 mg/dL and triglyceride <150 mg/dL. CAD events, which were defined as sudden cardiac death, acute coronary syndrome onset, and/or a need for coronary revascularization, were monitored for 12 years. First-time CAD events were observed in 110 men and 44 women. Kaplan-Meier event-free survival curves showed that patients with sdLDL-C ≥32.5 mg/dL (top quartile) had an increased risk of CAD events (log-rank P=0.009). The multivariate-adjusted hazard ratio (HR) in the top sdLDL-C quartile was 1.632 (95% confidence interval 1.159-2.297) and remained significant in 354 patients treated with statins (HR 1.582; P=0.041), whereas the risk in the top quartiles of LDL-C, non-HDL-C, apolipoprotein B, and triglyceride was not significantly higher relative to lower quartiles. Receiver operating characteristic curve analyses indicated that risk increased at cut-off values of sdLDL-C ≥32.2 mg/dL (HR 1.566; P=0.011) and sdLDL-C/LDL-C ratio ≥0.316 (HR 1.569; P=0.018). CONCLUSIONS: Although sdLDL is a feature of metabolic dyslipidemia, high sdLDL-C can predict long-term recurrence of CAD events even in patients without metabolic dyslipidemia.
Related
- Novel cholesterol-high-density lipoprotein-glucose index is associated with 1-year recurrence of atrial fibrillation after catheter ablation
- Triglyceride–high-density lipoprotein cholesterol–glucose–body mass index predicts 28-day all-cause mortality in critically ill patients with heart failure
- The cholesterol, high-density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new-onset cardiovascular-liver-metabolic multimorbidity: A prospective cohort study.
- Monocyte-to-high-density lipoprotein cholesterol ratio and carotid atherosclerosis in patients with metabolic dysfunction-associated steatotic liver disease: a comparative analysis of systemic inflammatory indices.
- Combined statin probiotic treatment mitigates atherogenic dyslipidemia fueling NAFLD in high-cholesterol-diet fed rats
BibTeX
@article{koba2026small,
title = {{Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia}},
author = {Shinji Koba and Yuya Yokota and Noriyuki Satoh and Yasuki Ito and Fumiyoshi Tsunoda and Koshiro Sakai and Yuya Nakamura and Makoto Shoji and Tsutomu Hirano and Toshiro Shinke},
journal = {Circulation Journal},
year = {2026},
month = jul,
doi = {10.1253/circj.cj-25-0805},
url = {https://www.jstage.jst.go.jp/article/circj/90/8/90_CJ-25-0805/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia
AU - Shinji Koba
AU - Yuya Yokota
AU - Noriyuki Satoh
AU - Yasuki Ito
AU - Fumiyoshi Tsunoda
AU - Koshiro Sakai
AU - Yuya Nakamura
AU - Makoto Shoji
AU - Tsutomu Hirano
AU - Toshiro Shinke
PY - 2026
DA - 2026/07/24
JO - Circulation Journal
DO - 10.1253/circj.cj-25-0805
UR - https://www.jstage.jst.go.jp/article/circj/90/8/90_CJ-25-0805/_article
AB - BACKGROUND: This study investigated whether small dense low-density lipoprotein cholesterol (sdLDL-C) can predict long-term coronary artery disease (CAD) events in patients with stable CAD without metabolic dyslipidemia. METHODS AND RESULTS: Directly measured sdLDL-C was evaluated in 396 male and 144 female patients with stable CAD who had high-density lipoprotein cholesterol (HDL-C) ≥40 mg/dL and triglyceride <150 mg/dL. CAD events, which were defined as sudden cardiac death, acute coronary syndrome onset, and/or a need for coronary revascularization, were monitored for 12 years. First-time CAD events were observed in 110 men and 44 women. Kaplan-Meier event-free survival curves showed that patients with sdLDL-C ≥32.5 mg/dL (top quartile) had an increased risk of CAD events (log-rank P=0.009). The multivariate-adjusted hazard ratio (HR) in the top sdLDL-C quartile was 1.632 (95% confidence interval 1.159-2.297) and remained significant in 354 patients treated with statins (HR 1.582; P=0.041), whereas the risk in the top quartiles of LDL-C, non-HDL-C, apolipoprotein B, and triglyceride was not significantly higher relative to lower quartiles. Receiver operating characteristic curve analyses indicated that risk increased at cut-off values of sdLDL-C ≥32.2 mg/dL (HR 1.566; P=0.011) and sdLDL-C/LDL-C ratio ≥0.316 (HR 1.569; P=0.018). CONCLUSIONS: Although sdLDL is a feature of metabolic dyslipidemia, high sdLDL-C can predict long-term recurrence of CAD events even in patients without metabolic dyslipidemia.
SN - 1347-4820
SN - 1346-9843
ER -